Get the Stockscreener App
0.882
4.22%
-0.0389
After Hours:
.88
-0.002
-0.23%
Biodesix Inc Stock (BDSX) Forecast
The Biodesix Inc (BDSX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5608, representing a -36.41% decrease from the current price of $0.882. The highest analyst price target is $0.8689, and the lowest is $0.2528.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BDSX Price Target
Average 2.7492
(+211.70% Upside)
Is Biodesix Inc (BDSX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 30.31 | Neutral |
| STOCH(9,6) | 28.12 | Neutral |
| STOCHRSI(14) | 12.08 | Buy |
| MACD(12,26) | -0.0741 | Buy |
| ADX(14) | 29.84 | Sell |
| William %R | -96.59 | Buy |
| CCI(14) | -123.45 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9507
Sell
|
0.9522
Sell
|
| MA20 |
0.9923
Sell
|
1.0038
Sell
|
| MA50 |
1.1947
Sell
|
1.1451
Sell
|
| MA100 |
1.3486
Sell
|
1.2877
Sell
|
| MA200 |
1.493
Sell
|
1.4127
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BDSX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on BDSX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 30.31 indicates that BDSX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.12 indicates that BDSX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.08 indicates that BDSX is oversold. This suggests that BDSX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.84 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -123.45 indicates that BDSX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term BDSX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Biodesix Inc financial reports and earnings history, Biodesix Inc (BDSX) stock could reach $12.06 by 2030, $4.8174 by 2040 and $43.62 by 2050. See the projected annual prices until 2050 of the Biodesix Inc stock below:
- Biodesix Inc (BDSX) is expected to reach an average price of $10.64 in 2035, with a high prediction of $10.96 and a low estimate of $10.77. This indicates an $1,107% rise from the last recorded price of $0.882.
- Biodesix Inc (BDSX) stock is projected to chart a bullish course in 2040, with an average price target of $4.6717, representing an $429.67% surge from its current level. The forecast ranges from a conservative $4.7317 to a sky-high $4.8174.
- Our analysts predict Biodesix Inc (BDSX) to jump 4,963% by 2045, soaring from $44.98 to an average price of $44.65, potentially reaching $45.76. While $44.98 is the low estimate, the potential upside is significant.
- Biodesix Inc (BDSX) stock is expected to climb by 2050, reaching an average of $42.28, a $4,693% jump from its current level. However, a wide range of estimates exists, with high and low targets of $43.62 and $42.64, respectively, highlighting the market's uncertainty.
Biodesix Inc Stock (BDSX) Year by Year Forecast
Biodesix Inc Stock (BDSX) Price Forecast for 2025
Biodesix Inc Stock (BDSX) is expected to reach an average price of $3.4474 in 2025, with a high prediction of $6.8217 and a low estimate of $0.0731. This indicates an +290.86% rise from the last recorded price of $0.882.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.0746 | $0.2528 | $0.8689 | -91.54% |
| April, 2025 | $0.4425 | $0.1632 | $1.4203 | -49.83% |
| May, 2025 | $0.8282 | $0.5839 | $0.6569 | -6.10% |
| June, 2025 | $1.9339 | $0.9425 | $0.6596 | +119.26% |
| July, 2025 | $3.231 | $2.0167 | $3.041 | +266.33% |
| August, 2025 | $3.1267 | $3.0053 | $3.0661 | +254.50% |
| September, 2025 | $3.9924 | $4.0281 | $3.7095 | +352.65% |
| October, 2025 | $5.2395 | $4.2738 | $4.9395 | +494.04% |
| November, 2025 | $5.5552 | $5.3323 | $5.3352 | +529.84% |
| December, 2025 | $5.3923 | $5.5266 | $5.2908 | +511.37% |
Biodesix Inc Stock (BDSX) Price Forecast for 2026
The predicted value for Biodesix Inc (BDSX) in 2026 is set at an average of $3.8549. Estimates vary from a peak of $5.248 to a trough of $2.4619, indicating an +337.07% surge from the present price of $0.882.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.268 | $5.3737 | $5.248 | +497.27% |
| February, 2026 | $5.1586 | $5.1936 | $5.2394 | +484.88% |
| March, 2026 | $4.5993 | $4.9193 | $5.0351 | +421.47% |
| April, 2026 | $3.5664 | $3.8164 | $4.3858 | +304.36% |
| May, 2026 | $4.1521 | $4.1279 | $4.0821 | +370.76% |
| June, 2026 | $4.5178 | $4.335 | $4.2878 | +412.22% |
| July, 2026 | $4.5349 | $4.5692 | $4.5049 | +414.16% |
| August, 2026 | $3.8906 | $4.1006 | $4.3963 | +341.11% |
| September, 2026 | $3.4577 | $3.5677 | $3.6049 | +292.03% |
| October, 2026 | $2.5234 | $2.7534 | $2.6606 | +186.10% |
| November, 2026 | $2.9191 | $2.5462 | $2.6391 | +230.96% |
| December, 2026 | $2.9062 | $2.4619 | $2.4205 | +229.50% |
Biodesix Inc Stock (BDSX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Biodesix Inc (BDSX) is $1.2601, with a high forecast of $2.5004 and a low forecast of $0.0199. This indicates an +42.87% increase from the last price of $0.882.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.5619 | $2.6019 | $2.4836 | +190.46% |
| February, 2027 | $2.4676 | $2.5547 | $2.4333 | +179.77% |
| March, 2027 | $2.4947 | $2.5147 | $2.5004 | +182.84% |
| April, 2027 | $2.4204 | $2.4274 | $2.3704 | +174.42% |
| May, 2027 | $2.3861 | $2.4049 | $2.2746 | +170.53% |
| June, 2027 | $1.5532 | $1.7531 | $2.2175 | +76.10% |
| July, 2027 | $1.6288 | $1.6145 | $1.5288 | +84.68% |
| August, 2027 | $1.2895 | $1.31 | $1.4203 | +46.21% |
| September, 2027 | $1.3816 | $1.286 | $1.1688 | +56.65% |
| October, 2027 | $0.8973 | $0.9773 | $1.0631 | +1.74% |
| November, 2027 | $0.353 | $0.493 | $0.6788 | -59.98% |
| December, 2027 | $0.0499 | $0.0199 | $0.1244 | -94.35% |
Biodesix Inc Stock (BDSX) Price Forecast for 2028
In 2028, Biodesix Inc (BDSX) is projected to reach an average price of $5.4037, with a high projection of $10.80 and a low estimate of $0.0115. This indicates an +512.66% rise from the last price of $0.882.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1758 | $0.0985 | $0.357 | -80.07% |
| February, 2028 | $0.0915 | $0.1287 | $0.2713 | -89.63% |
| March, 2028 | $0.0686 | $0.0643 | $0.1342 | -92.22% |
| April, 2028 | $9.93 | $0.0115 | $7.77 | +1,026% |
| May, 2028 | $6.3592 | $5.0714 | $9.1228 | +621.00% |
| June, 2028 | $1.3256 | $4.0456 | $5.0771 | +50.29% |
| July, 2028 | $3.083 | $0.113 | $10.80 | +249.55% |
| August, 2028 | $2.2712 | $0.6373 | $7.5545 | +157.50% |
| September, 2028 | $0.0874 | $0.6931 | $4.4931 | -90.09% |
| October, 2028 | $1.8639 | $0.2254 | $0.7518 | +111.33% |
| November, 2028 | $4.8981 | $4.3668 | $5.7753 | +455.35% |
| December, 2028 | $4.7695 | $4.8867 | $3.5838 | +440.76% |
Biodesix Inc Stock (BDSX) Price Forecast for 2029
The 2029 price forecast for Biodesix Inc Stock (BDSX) is $9.4613 on average, with a high prediction of $12.58 and a low estimate of $6.3424. This represents an +972.71% increase from the previous price of $0.882.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.5537 | $6.3424 | $7.2132 | +869.81% |
| February, 2029 | $10.13 | $9.3394 | $9.5851 | +1,048% |
| March, 2029 | $8.0365 | $8.5665 | $8.698 | +811.17% |
| April, 2029 | $8.5779 | $9.0443 | $8.5579 | +872.55% |
| May, 2029 | $9.4121 | $9.7121 | $9.2136 | +967.13% |
| June, 2029 | $9.6134 | $9.3049 | $9.5906 | +989.96% |
| July, 2029 | $11.44 | $11.13 | $11.11 | +1,198% |
| August, 2029 | $12.25 | $10.93 | $11.49 | +1,289% |
| September, 2029 | $12.00 | $11.87 | $11.47 | +1,261% |
| October, 2029 | $12.51 | $12.61 | $12.42 | +1,319% |
| November, 2029 | $12.62 | $12.68 | $12.58 | +1,330% |
| December, 2029 | $11.91 | $12.33 | $12.34 | +1,250% |
Biodesix Inc Stock (BDSX) Price Forecast for 2030
Biodesix Inc Stock (BDSX) is expected to reach an average price of $9.5699 in 2030, with a high forecast of $12.06 and a low forecast of $7.0839. This signifies an +985.02% surge from the last price of $0.882.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.97 | $12.07 | $12.06 | +1,257% |
| February, 2030 | $11.39 | $11.75 | $11.60 | +1,192% |
| March, 2030 | $10.66 | $11.02 | $11.28 | +1,109% |
| April, 2030 | $10.16 | $9.9929 | $10.34 | +1,051% |
| May, 2030 | $10.09 | $10.19 | $10.06 | +1,044% |
| June, 2030 | $10.24 | $10.31 | $10.08 | +1,061% |
| July, 2030 | $9.8255 | $9.8955 | $10.08 | +1,014% |
| August, 2030 | $8.9769 | $9.0869 | $9.2984 | +917.79% |
| September, 2030 | $7.8183 | $8.4883 | $8.8097 | +786.43% |
| October, 2030 | $7.2325 | $7.3625 | $7.6711 | +720.01% |
| November, 2030 | $6.9939 | $7.0839 | $7.3582 | +692.96% |
| December, 2030 | $7.0252 | $7.1767 | $6.9112 | +696.51% |
0.06%
3.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):